<DOC>
	<DOC>NCT01152372</DOC>
	<brief_summary>Evaluate the modified GDT as a measure of key metabolic characteristics in healthy subjects and those with type 2 diabetes mellitus</brief_summary>
	<brief_title>Experimental Study to Validate the Modified Glucose Disposal Test</brief_title>
	<detailed_description />
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical diagnosis of Type 2 diabetes Clinically healthy Drug naive or on a stable dose of metformin monotherapy and/or a secretagogue Type 1 Diabetes History of significant heart disease. Bariatric surgery Exposure to fibrates, thiazolidinediones, insulin, exenatide, pramlintide or DPPIV inhibitors</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2010</verification_date>
</DOC>